abs62.txt	background		methods	developed	to	estimate	intervention	effects	in	external	targetpopulations	assume	that	all	important	effect	measure	modifiers	have	beenidentified	and	appropriately	modeled	propensity	score-based	diagnostics	can	beused	assess	the	plausibility	of	these	assumptions	for	weighting	we	demonstrate	use	when	assessing	thetransportability	treatment	from	standard	care	metastaticcolorectal	cancer	control	arm	a	phase	iii	trial	(horizon	iii)	targetpopulation	1	942	medicare	beneficiaries	aged	65+	years	results	an	unadjusted	comparison	participants	had	lowermortality	compared	with	target	population	patients	treated	ofcare	therapy	[trial	vs	hazard	ratio	(hr)=	0	72	95%	confidence	interval(ci)	58	89]	applying	inverse	odds	sampling	weights	attenuated	trialvs	hr	(weighted	hr=0	96	ci	73	26)	however	whether	unadjustedor	weighted	hazards	did	not	appear	proportional	at	6	months	follow-up	mortality	was	lower	than	population(weighted	risk	difference	(rd)	=	-0	07	13	01)	but	12	rd=	00	09	09)	conclusion	suggest	direct	transport	fromhorizon	is	valid	proposedsampling	model	might	allow	onlonger-term	horizon	inclinical	practice
